Compile Data Set for Download or QSAR
Report error Found 9 Enz. Inhib. hit(s) with all data for entry = 12141
TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682238(US20240207267, Example 7)
Affinity DataIC50: 22nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682242(US20240207267, Example 14)
Affinity DataIC50: 24nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682236(US20240207267, Example 5 | Step 1: methyl (R)-1-(4...)
Affinity DataIC50: 26nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682241(US20240207267, Example 13)
Affinity DataIC50: 27nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682239(US20240207267, Example 9 | 3-(2,6-difluoro-4-(3-(h...)
Affinity DataIC50: 64nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682240(US20240207267, Example 12 | (3R)-1-(4-(2,6-dioxopi...)
Affinity DataIC50: 178nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682243(US20240207267, Example 15 | 3-(4-(2-hydroxyethyl)p...)
Affinity DataIC50: 239nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682235(US20240207267, Example 2)
Affinity DataIC50: 406nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent

TargetDNA damage-binding protein 1/Protein Cereblon [40-442](Homo sapiens (Human))
Beigene Switzerland

US Patent
LigandPNGBDBM682237(US20240207267, Example 6)
Affinity DataIC50: 1.07E+3nMAssay Description:Biochemical potency of compound was determined by using CRBN& DDB1 protein (His Tag). Compounds were tested for blocking the binding of CRBN&DDB1 pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2024
Entry Details
US Patent